It’s difficult to make it as a biotech company and I would say stem cell biotechs in general may have an even rougher time. One such company, Intellicell (Intellicell Biosciences, Inc), is showing a number of signs of distress in my [...]
The post Stem cell company Intellicell facing new financial wrinkles appeared first on The Niche.
